No abstract available
Keywords:
autoimmune diseases; biological therapy; glucocorticoids.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antirheumatic Agents / therapeutic use*
-
Antiviral Agents / therapeutic use*
-
Arthritis, Psoriatic / complications
-
Arthritis, Psoriatic / drug therapy
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy
-
Azithromycin / therapeutic use
-
Betacoronavirus
-
COVID-19
-
COVID-19 Drug Treatment
-
Cohort Studies
-
Coronavirus Infections / complications
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / mortality
-
Coronavirus Infections / physiopathology*
-
Coronavirus Infections / therapy
-
Drug Combinations
-
Female
-
Glucocorticoids / therapeutic use*
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunologic Factors / therapeutic use*
-
Lopinavir / therapeutic use
-
Lupus Erythematosus, Systemic / complications
-
Lupus Erythematosus, Systemic / drug therapy
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / physiopathology*
-
Pneumonia, Viral / therapy
-
Retrospective Studies
-
Rheumatic Diseases / complications
-
Rheumatic Diseases / drug therapy*
-
Ritonavir / therapeutic use
-
SARS-CoV-2
-
Severity of Illness Index
-
Spondylarthropathies / complications
-
Spondylarthropathies / drug therapy
Substances
-
Antirheumatic Agents
-
Antiviral Agents
-
Drug Combinations
-
Glucocorticoids
-
Immunoglobulins, Intravenous
-
Immunologic Factors
-
lopinavir-ritonavir drug combination
-
Lopinavir
-
Hydroxychloroquine
-
Azithromycin
-
Ritonavir